生晶藥廠BCRX

那斯達克 · USD
8.48
-0.02
(-0.24%)
收盤 03/07 04:59 (UTC+8)
03/07 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.87
  • 0.93
  • 0.93
  • 1.09
  • 1.17
  • 1.32
  • 1.46
  • 1.63
  • 1.59
  • 4.07
icon
  • 5.15
  • 7.68
  • -0.69
  • 17.86
  • 7.09
  • 12.34
  • 10.64
  • 12.24
  • -2.42
  • 155.06
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
406,555
159,395
163,353
145,534
131,534
117,085
109,332
92,761
93,401
86,742
營業成本
9,5222,1872,7984,5686,0943,2111,6991,2651,5571,099
營業毛利
397,033
157,208
160,555
140,966
125,440
113,874
107,633
91,496
91,844
85,643
營業費用
136,648127,617130,769-129,948106,182--134,51497,564
研發費用
40,86744,60343,38637,27049,44141,08137,62346,49370,05246,879
推銷及管理費用
95,78183,01487,38382,46980,29165,08461,08759,36464,38250,648
非經常性項目費用
----216171621278037
其他營業費用
----------
營業利益
260,385
29,591
29,786
21,227
-4,508
7,692
8,761
-14,488
-42,670
-11,921
其他收入及費用
1,7672,200-1,7183,0252,9663,6893,4703,9804,0913,447
利息費用
14,13519,66121,58223,49424,44924,82824,73324,50624,58327,345
稅前純益
248,017
12,130
6,486
758
-25,991
-13,447
-12,502
-35,014
-63,162
-35,819
所得稅
2,172-7691,401726804586172365-1,431330
稅後純益
245,845
12,899
5,085
32
-26,795
-14,033
-12,674
-35,379
-61,731
-36,149
基本每股稅後盈餘(元)
1.180.060.020.00-0.13-0.07-0.06-0.17-0.31-0.19
稀釋每股稅後盈餘(元)
1.130.060.020.00-0.13-0.07-0.06-0.17-0.31-0.19
基本平均股數(千股)
210995.00210176.00209519.00208882.00207381.00206905.00206425.00206064.00201409.00189644.00
稀釋平均股數(千股)
219292.00219885.00219886.00215261.00207381.00206905.00206425.00206064.00201409.00189644.00
還原基本每股稅後盈餘(元)
1.180.060.020.00-0.13-0.07-0.06-0.17-0.31-0.19
還原稀釋每股稅後盈餘(元)
1.130.060.020.00-0.13-0.07-0.06-0.17-0.31-0.19
還原基本平均股數(千股)
210,995210,176209,519208,882207,381206,905206,425206,064201,409189,644
還原稀釋平均股數(千股)
219,292219,885219,886215,261207,381206,905206,425206,064201,409189,644
EBITDA(千元)
261,45531,41927,24723,200-3,9939,6539,058-13,383-41,605-10,651

大家都在看

HOT